(Q44437781)

English

Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study

scientific article published in May 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Ximelagatran versus warfarin for stroke prevention in patients with nonvalvular atrial fibrillation. SPORTIF II: a dose-guiding, tolerability, and safety study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

atrial fibrillation

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Palle Petersen

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Margaretha Grind

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

John Adler

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

SPORTIF II Investigators

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1445-1451

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Canadian atrial fibrillation anticoaguiation (CAFA) study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Stroke Prevention in Atrial Fibrillation Study. Final results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

SPAF-III results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Co

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Why do patients with atrial fibrillation not receive warfarin?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Interobserver agreement for the assessment of handicap in stroke patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Barthel ADL Index: a reliability study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900255-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(03)00255-9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44437781&oldid=2023585766"